back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-08 14:49 Tx date 2024-01-05 |
$ACST
Acasti Pharma Inc. |
DelAversano, Robert John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
42,000 | ||
| Filed 2023-12-20 19:13 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,017 | |
| Filed 2023-12-20 19:11 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,668 vol |
324,854 | |
| Filed 2023-12-20 19:10 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
22,500 | |
| Filed 2023-12-20 19:09 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2023-12-20 19:08 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
22,500 | |
| Filed 2023-12-20 19:07 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2023-12-20 19:07 Tx date 2023-10-10 |
$ACST
Acasti Pharma Inc. |
Neugeboren, Edward
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-20 19:06 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
22,500 | |
| Filed 2023-12-20 19:05 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2023-12-20 19:05 Tx date 2023-10-10 |
$ACST
Acasti Pharma Inc. |
Davis, Alfred Brian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-28 12:01 Tx date 2023-09-25 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Warrants Private Offering Sept 2023
11 - Acquisition or disposition carried out privately
|
+422,732 vol |
422,732 | |
| Filed 2023-09-28 12:00 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Warrants Private Offering Sept 2023
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-28 12:00 Tx date 2023-09-25 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
11 - Acquisition or disposition carried out privately
|
$1,250,001
+676,371 vol $1.85 each |
1,188,076 | |
| Filed 2023-09-05 16:32 Tx date 2023-08-31 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$781.05
+381 vol $2.05 each |
381 | |
| Filed 2023-09-05 16:18 Tx date 2018-04-27 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-14 19:54 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Derby, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
26,667 | |
| Filed 2023-07-14 19:52 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
30,938 | |
| Filed 2023-07-14 19:51 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
27,017 | |
| Filed 2023-07-14 19:50 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,668 vol |
283,186 | |
| Filed 2023-07-14 19:49 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+208,334 vol |
241,518 | |
| Filed 2023-07-14 19:48 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,000 vol |
42,000 | |
| Filed 2023-07-14 19:47 Tx date 2023-05-08 |
$ACST
Acasti Pharma Inc. |
Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-14 19:46 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
D'Andrea, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,000 vol |
42,000 | |
| Filed 2023-07-14 19:46 Tx date 2023-05-08 |
$ACST
Acasti Pharma Inc. |
D'Andrea, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-14 19:42 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Macdonald, Robert Loch
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
60,000 | |
| Filed 2023-07-14 19:41 Tx date 2023-05-08 |
$ACST
Acasti Pharma Inc. |
Macdonald, Robert Loch
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-14 19:36 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+792 vol |
792 | |
| Filed 2023-07-14 19:36 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-38,000 vol |
0 | |
| Filed 2023-07-14 19:35 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+18,438 vol |
18,438 | |
| Filed 2023-07-14 19:35 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-275,300 vol |
0 | |
| Filed 2023-07-14 19:32 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+21,357 vol |
21,357 | |
| Filed 2023-07-14 19:32 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-128,138 vol |
0 | |
| Filed 2023-07-14 19:32 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+33,184 vol |
33,184 | |
| Filed 2023-07-14 19:31 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-199,100 vol |
0 | |
| Filed 2023-07-14 19:30 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+511,705 vol |
511,705 | |
| Filed 2023-07-14 19:30 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-3,070,229 vol |
0 | |
| Filed 2023-07-14 19:29 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+124,344 vol |
124,344 | |
| Filed 2023-07-14 19:29 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-746,064 vol |
0 | |
| Filed 2023-07-14 19:28 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+14,517 vol |
14,517 | |
| Filed 2023-07-14 19:27 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-87,100 vol |
0 | |
| Filed 2023-07-14 19:26 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Rajitha Grace 2018 Irrevocable Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+781,592 vol |
781,592 | |
| Filed 2023-07-14 19:25 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Rajitha Grace 2018 Irrevocable Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-4,689,547 vol |
0 | |
| Filed 2023-07-14 19:20 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+11,119 vol |
11,119 | |
| Filed 2023-07-14 19:20 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-66,712 vol |
0 | |
| Filed 2023-07-14 19:18 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+75,484 vol |
75,484 | |
| Filed 2023-07-14 19:17 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-452,900 vol |
0 | |
| Filed 2023-07-14 19:13 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Derby, Michael
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+14,167 vol |
14,167 | |
| Filed 2023-07-14 19:13 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Derby, Michael
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-85,000 vol |
0 | |
| Filed 2023-05-16 09:29 Tx date 2023-05-08 |
$ACST
Acasti Pharma Inc. |
Kumar, Amresh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
66,712 | ||
| Filed 2022-09-29 13:54 Tx date 2022-09-28 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
275,300 | |
| Filed 2022-09-29 13:52 Tx date 2022-09-28 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
87,100 | |
| Filed 2022-09-29 13:51 Tx date 2022-09-28 |
$ACST
Acasti Pharma Inc. |
Derby, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
85,000 | |
| Filed 2022-09-29 13:50 Tx date 2022-03-24 |
$ACST
Acasti Pharma Inc. |
Derby, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-29 13:48 Tx date 2022-09-28 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
371,083 | |
| Filed 2022-09-13 16:56 Tx date 2022-09-09 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
199,100 | ||
| Filed 2022-09-13 16:55 Tx date 2022-09-09 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
128,138 | ||
| Filed 2022-06-23 15:56 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
337,900 | |
| Filed 2022-06-23 15:53 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+165,000 vol |
452,900 | |
| Filed 2022-06-23 15:49 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+165,000 vol |
2,016,215 | |
| Filed 2022-06-23 15:39 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+560,000 vol |
5,409,748 | |
| Filed 2021-11-15 14:31 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+287,900 vol |
287,900 | |
| Filed 2021-11-15 14:30 Tx date 2020-09-14 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-15 14:28 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+287,900 vol |
287,900 | |
| Filed 2021-11-15 14:27 Tx date 2021-11-10 |
$ACST
Acasti Pharma Inc. |
Kottayil, George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-15 14:26 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+287,900 vol |
1,851,215 | |
| Filed 2021-11-15 14:21 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+655,500 vol |
4,849,748 | |
| Filed 2021-11-15 14:15 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Haseltine, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
42,100 | |
| Filed 2021-11-15 14:14 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Haseltine, William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-15 14:11 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
42,100 | |
| Filed 2021-11-15 14:10 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-15 14:08 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
230,300 | |
| Filed 2021-11-15 14:03 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
326,083 | |
| Filed 2021-11-15 14:01 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
547,677 | |
| Filed 2021-09-07 10:00 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Haseltine, William
4 - Director of Issuer
Holder: William A. Haseltine 2001 Revocable Trust (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
325,731 | ||
| Filed 2021-09-07 09:53 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
746,064 | ||
| Filed 2021-09-07 09:49 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Rajitha Grace 2018 Irrevocable Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
4,689,547 | ||
| Filed 2021-09-03 14:24 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
3,070,229 | ||
| Filed 2021-09-03 14:03 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Haseltine, William
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
332,837 | ||
| Filed 2020-04-03 15:49 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+17,500 vol |
17,500 | |
| Filed 2020-04-03 15:47 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$50,750
+35,000 vol $1.45 each |
40,000 | |
| Filed 2017-02-27 17:20 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+26,250 vol |
||
| Filed 2017-02-27 17:19 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
||
| Filed 2020-04-01 15:58 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+86,000 vol |
188,200 | |
| Filed 2020-04-01 15:56 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+86,000 vol |
283,983 | |
| Filed 2020-04-01 15:54 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+86,000 vol |
505,577 | |
| Filed 2020-04-01 15:50 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+253,000 vol |
528,000 | |
| Filed 2020-04-01 15:45 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+587,000 vol |
1,563,315 | |
| Filed 2020-04-01 15:43 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+587,000 vol |
1,037,000 | |
| Filed 2020-04-01 15:38 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,335,000 vol |
4,194,248 | |
| Filed 2019-08-20 09:04 Tx date 2019-08-19 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$3,016
+1,600 vol $1.89 each |
117,500 | |
| Filed 2019-08-20 09:04 Tx date 2019-08-19 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$15,876
+8,400 vol $1.89 each |
115,900 | |
| Filed 2019-04-15 14:08 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,136
+58,700 vol $1.28 each |
197,983 | |
| Filed 2019-04-15 14:06 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,096
+78,200 vol $1.28 each |
419,577 | |
| Filed 2019-04-15 14:04 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,816
+52,200 vol $1.28 each |
102,200 | |
| Filed 2019-04-15 14:02 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$96,000
+75,000 vol $1.28 each |
275,000 | |
| Filed 2019-04-15 14:00 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,000
+150,000 vol $1.28 each |
450,000 | |
| Filed 2019-04-15 13:59 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$448,000
+350,000 vol $1.28 each |
976,315 | |
| Filed 2019-04-15 13:55 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,277,440
+998,000 vol $1.28 each |
2,859,248 | |
| Filed 2018-10-24 Tx date 2018-10-23 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$48,640
+38,000 vol $1.28 each |
38,000 | |
| Filed 2018-10-24 Tx date 2018-04-27 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-23 Tx date 2018-10-09 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$50,000
+50,000 vol $1.00 each |
107,500 | |
| Filed 2018-10-09 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-09 Tx date 2018-10-05 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$9,323
+7,301 vol $1.28 each |
349,601 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-5,709.74
-4,261 vol $1.34 each |
345,340 | |
| Filed 2018-10-09 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$200,000
+200,000 vol $1.00 each |
200,000 | |
| Filed 2018-10-09 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$341,954
+337,900 vol $1.01 each |
387,900 | |
| Filed 2018-10-09 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-64,569.60
-45,600 vol $1.42 each |
342,300 | |
| Filed 2018-10-04 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Hamilton, James Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$18,500
+10,000 vol $1.85 each |
10,000 | |
| Filed 2018-09-25 Tx date 2018-09-21 |
$ACST
Acasti Pharma Inc. |
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
||
| Filed 2018-09-25 Tx date 2018-09-21 |
$ACST
Acasti Pharma Inc. |
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2018-09-24 Tx date 2018-09-21 |
$ACST
Acasti Pharma Inc. |
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-24 Tx date 2018-09-21 |
$ACST
Acasti Pharma Inc. |
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2018-07-04 Tx date 2018-04-27 |
$ACST
Acasti Pharma Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+365,515 vol |
626,315 | |
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2018-07-04 Tx date 2018-06-01 |
$ACST
Acasti Pharma Inc. |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+906,248 vol |
1,861,248 | |
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,377 vol |
341,377 | |
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,283 vol |
139,283 | |
| Filed 2018-03-20 Tx date 2018-03-17 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
| Filed 2018-03-20 Tx date 2018-03-17 |
$ACST
Acasti Pharma Inc. |
Crewe, Katherine
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
| Filed 2017-11-23 Tx date 2017-11-20 |
$ACST
Acasti Pharma Inc. |
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-2,505.09
-1,057 vol $2.37 each |
3,222 | |
| Filed 2017-11-23 Tx date 2017-11-20 |
$ACST
Acasti Pharma Inc. |
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-1,452
-600 vol $2.42 each |
4,279 | |
| Filed 2017-11-23 Tx date 2017-11-20 |
$ACST
Acasti Pharma Inc. |
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-8,743.20
-3,643 vol $2.40 each |
4,879 | |
| Filed 2017-11-23 Tx date 2017-11-20 |
$ACST
Acasti Pharma Inc. |
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-11,400
-5,000 vol $2.28 each |
0 | |
| Filed 2017-11-23 Tx date 2017-11-21 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-123,389.59
-51,199 vol $2.41 each |
||
| Filed 2017-11-23 Tx date 2017-11-20 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-123,389.59
-51,199 vol $2.41 each |
0 | |
| Filed 2017-11-23 Tx date 2017-08-15 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
51,199 | ||
| Filed 2017-09-05 Tx date 2017-08-31 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,000
+50,000 vol $1.60 each |
50,000 | |
| Filed 2017-09-05 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-05 Tx date 2017-08-31 |
$ACST
Acasti Pharma Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,000
+50,000 vol $1.60 each |
50,000 | |
| Filed 2017-09-05 Tx date 2015-07-14 |
$ACST
Acasti Pharma Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-30 Tx date 2017-08-07 |
$ACST
Acasti Pharma Inc. |
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-11,500
-1,000 vol $11.50 each |
0 | |
| Filed 2017-06-20 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+17,241 vol |
17,241 | |
| Filed 2017-06-20 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+25,862 vol |
||
| Filed 2017-06-20 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$50,000
+34,483 vol $1.45 each |
34,983 | |
| Filed 2017-06-20 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$74,999
+51,724 vol $1.45 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,798
+17,400 vol $1.77 each |
67,400 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$138,060
+78,000 vol $1.77 each |
278,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,100
+130,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,610
+93,000 vol $1.77 each |
198,800 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,350
+155,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,820
+66,000 vol $1.77 each |
148,200 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$194,700
+110,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$456,660
+258,000 vol $1.77 each |
783,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$761,100
+430,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$54,162
+30,600 vol $1.77 each |
240,600 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,270
+51,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,798
+17,400 vol $1.77 each |
67,400 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
||
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,532
+11,600 vol $1.77 each |
90,600 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
79,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,040
+52,000 vol $1.77 each |
382,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,100
+130,000 vol $1.77 each |
330,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$109,740
+62,000 vol $1.77 each |
322,800 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,350
+155,000 vol $1.77 each |
260,800 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,880
+44,000 vol $1.77 each |
236,200 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$194,700
+110,000 vol $1.77 each |
192,200 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$304,440
+172,000 vol $1.77 each |
1,127,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$761,100
+430,000 vol $1.77 each |
955,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,108
+20,400 vol $1.77 each |
281,400 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,270
+51,000 vol $1.77 each |
261,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,532
+11,600 vol $1.77 each |
90,600 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
79,000 | |
| Filed 2017-06-13 Tx date 2017-06-13 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$850.00
+500 vol $1.70 each |
81,224 | |
| Filed 2017-06-13 Tx date 2017-06-12 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$6,290
+3,700 vol $1.70 each |
80,724 | |
| Filed 2017-06-13 Tx date 2017-06-08 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$9,010
+5,300 vol $1.70 each |
77,024 | |
| Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Vaugeois, Marc
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000 | ||
| Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Brouillette, François-Karl
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Brouillette, François-Karl
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Vaugeois, Marc
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-02 Tx date 2017-05-30 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$7,591
+4,500 vol $1.69 each |
71,724 | |
| Filed 2017-05-29 Tx date 2017-05-26 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$8,400
+5,000 vol $1.68 each |
67,224 | |
| Filed 2017-05-29 Tx date 2017-05-25 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$17,000
+10,000 vol $1.70 each |
62,224 | |
| Filed 2017-04-13 Tx date 2017-04-11 |
$ACST
Acasti Pharma Inc. |
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Groupe 11A
52 - Expiration of options
|
$-157,500
-7,500 vol $21.00 each |
0 | |
| Filed 2017-04-13 Tx date 2017-04-11 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-315,000
-15,000 vol $21.00 each |
105,800 | |
| Filed 2017-04-13 Tx date 2017-04-11 |
$ACST
Acasti Pharma Inc. |
Huart, Benoît
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-105,000
-5,000 vol $21.00 each |
3,600 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
50,000 | |
| Filed 2017-03-01 Tx date 2015-07-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,000
+200,000 vol $1.65 each |
200,000 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
120,800 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
82,200 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
50,000 | |
| Filed 2017-03-01 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-01 Tx date 2017-02-28 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-14,210.07
-9,051 vol $1.57 each |
51,199 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
97 - Other
|
$94,200
+60,000 vol $1.57 each |
60,250 | |
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+15,000 vol |
15,000 | |
| Filed 2017-02-27 Tx date 2016-11-27 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$43,500
+30,000 vol $1.45 each |
30,000 | |
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+25,862 vol |
25,862 | |
| Filed 2017-02-27 Tx date 2014-06-19 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$74,999
+51,724 vol $1.45 each |
52,224 | |
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+26,250 vol |
26,250 | |
| Filed 2017-02-27 Tx date 2016-05-12 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-22 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
52,500 | |
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+26,250 vol |
26,250 | |
| Filed 2017-02-27 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
57,500 | |
| Filed 2017-02-09 Tx date 2016-10-01 |
$ACST
Acasti Pharma Inc. |
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,500 vol |
32,200 |